Skip to content

FAIR metadata

Why post-hoc curation fails for NAM platforms

Damien Huzard, PhD

Post-hoc curation is often treated as a practical compromise: run the assays now, clean the metadata later. For NAM platforms, that compromise is structurally weak because the most important context is often lost before curation begins.

Some metadata cannot be reconstructed

A curator can normalize a column name after the fact. They usually cannot reconstruct a missing protocol deviation, undocumented matrix lot, donor characteristic, flow parameter, exposure timing, acceptance criterion, or analysis setting with confidence. NAM platforms are sensitive to these details because the biological and technical setup is part of the model.

That makes retrospective curation a poor foundation for regulatory or AI-ready evidence. It may improve a dataset enough for local search, but it cannot make uncertain provenance certain.

The failure mode is already visible in other domains

Studies of biomedical and omics metadata repeatedly show the same pattern: missing, inconsistent, or non-machine-readable metadata prevents secondary analysis and reuse. Sample attributes may be encoded in spreadsheets, PDFs, free text, or repository fields that are not controlled. Natural language processing can help extract metadata, but it is a repair strategy, not a substitute for capture at source.

For NAMs, the risk is higher because batch effects, device parameters, differentiation protocols, and endpoint processing can directly change interpretation. If those fields are missing, the dataset may remain technically available but scientifically under-specified.

Organoid and MPS platforms amplify the problem

Organoid and MPS systems are attractive because they capture human-relevant biology. They are also vulnerable to variability from matrix composition, cell source, differentiation protocol, fluid dynamics, device architecture, and analytical readouts. Standardisation discussions in organoid biology increasingly focus on SOPs, quality controls, data annotations, and benchmark metrics for exactly this reason.

A post-hoc curator looking at results cannot reliably infer which subtle protocol choices drove an observed difference. That knowledge has to be recorded while the experiment is designed and run.

Move curation into the workflow

The practical answer is not to abandon curation. It is to move curation upstream. Required metadata fields should be embedded in protocol templates, ELN forms, instrument exports, LIMS records, and analysis pipelines. Validation should happen before data enters the warehouse. Human review should focus on ambiguous fields, not on reconstructing entire studies from fragments.

For NAM platforms, post-hoc curation should be the exception handler. The primary system should capture structured metadata at source.

Sources and further reading

  1. Perceptual and technical barriers in sharing and formatting metadata accompanying omics studies — Review of metadata barriers, reproducibility, secondary analysis, and machine-assisted science.
  2. Challenges to sharing sample metadata in computational genomics — Frontiers in Genetics, 2023. Non-machine-readable and schema-less metadata limit reuse.
  3. Metadata in the BioSample Online Repository are Impaired by Numerous Anomalies — Analysis of non-standardized metadata fields and values in BioSample.
  4. Organoids as Miniature Twins - Challenges for Comparability and Need for Data Standardization and Access — Fraunhofer. Organoid reproducibility, comparability, standardization, and ethical provenance.
  5. Organoid Models: Advancements, Applications, and Future Directions — Review discussing organoid standardisation, matrix variability, quality control, and reproducibility.

Work with Neuronautix

Capture NAM metadata at source

Neuronautix helps teams move metadata capture upstream into protocol design, instrument workflows, assay execution, and analysis freeze.